• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

作者信息

Pestalozzi B, Castiglione M

机构信息

Klinik und Poliklinik für Onkologie, Universitätsspital Zürich, Zürich, Switzerland.

出版信息

Ann Oncol. 2008 May;19 Suppl 2:ii7-10. doi: 10.1093/annonc/mdn071.

DOI:10.1093/annonc/mdn071
PMID:18456775
Abstract
摘要

相似文献

1
Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.原发性乳腺癌：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii7-10. doi: 10.1093/annonc/mdn071.
2
Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer.辅助性曲妥珠单抗：HER-2阳性早期乳腺癌治疗的一个里程碑。
Oncologist. 2006;11 Suppl 1:4-12. doi: 10.1634/theoncologist.11-90001-4.
3
[Adjuvant therapy with trastuzumab (Herceptin) in primary breast cancer].[曲妥珠单抗（赫赛汀）用于原发性乳腺癌的辅助治疗]
Zentralbl Gynakol. 2006 Feb;128(1):30-7. doi: 10.1055/s-2006-921382.
4
Her2 and trastuzumab in breast cancer.人表皮生长因子受体2（Her2）与曲妥珠单抗在乳腺癌中的作用
Cancer Control. 2001 Jan-Feb;8(1):103-10. doi: 10.1177/107327480100800113.
5
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.曲妥珠单抗辅助化疗后治疗 1 年用于人表皮生长因子受体 2 阳性早期乳腺癌患者：一项随机对照试验的 4 年随访。
Lancet Oncol. 2011 Mar;12(3):236-44. doi: 10.1016/S1470-2045(11)70033-X. Epub 2011 Feb 25.
6
Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.原发性乳腺癌：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2007 Apr;18 Suppl 2:ii5-8. doi: 10.1093/annonc/mdm015.
7
ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer.欧洲肿瘤内科学会关于原发性乳腺癌诊断、辅助治疗及随访的最低临床建议
Ann Oncol. 2001 Aug;12(8):1047-8. doi: 10.1023/a:1017448816215.
8
Adjuvant trastuzumab in early breast cancer.早期乳腺癌的辅助性曲妥珠单抗治疗
Ann Oncol. 2006 Sep;17 Suppl 10:x54-8. doi: 10.1093/annonc/mdl237.
9
Phase I/II study of treatment of stage IV breast cancer with OKT3 x trastuzumab-armed activated T cells.OKT3联合曲妥珠单抗武装的活化T细胞治疗IV期乳腺癌的I/II期研究
Clin Breast Cancer. 2003 Aug;4(3):212-7. doi: 10.3816/cbc.2003.n.028.
10
Reviewing prognostic factors in breast cancer management.
JAAPA. 2007 May;20(5):42-6. doi: 10.1097/01720610-200705000-00009.

引用本文的文献

1
Adjuvant Chemotherapy for Patients with Breast Cancer Based on Clinical and Evolving Oncotype DX Criteria.基于临床及不断发展的Oncotype DX标准的乳腺癌患者辅助化疗
Breast Care (Basel). 2020 Dec;15(6):642-647. doi: 10.1159/000506389. Epub 2020 Mar 10.
2
Androgen Receptor Expression in an Indian Breast Cancer Cohort with Relation to Molecular Subtypes and Response to Neoadjuvant Chemotherapy - a Prospective Clinical Study.印度乳腺癌队列中雄激素受体表达与分子亚型及新辅助化疗反应的关系——一项前瞻性临床研究
Breast Care (Basel). 2017 Jul;12(3):160-164. doi: 10.1159/000458433. Epub 2017 Jun 16.
3
Distribution of breast cancer subtypes among Jordanian women and correlation with histopathological grade: molecular subclassification study.
约旦女性乳腺癌亚型的分布及其与组织病理学分级的相关性：分子亚分类研究
JRSM Short Rep. 2013 Sep 13;4(10):2042533313490516. doi: 10.1177/2042533313490516. eCollection 2013.
4
Prognosis in women with breast cancer and private extra insurance coverage.乳腺癌女性患者的预后与私人额外保险覆盖范围。
Ann Surg Oncol. 2013 Sep;20(9):2822-7. doi: 10.1245/s10434-013-3025-3. Epub 2013 Jun 11.
5
SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?SULT1A1 rs9282861 多态性——乳腺癌全身辅助治疗疗效的潜在调节剂？
BMC Cancer. 2012 Jun 18;12:257. doi: 10.1186/1471-2407-12-257.
6
Options for early breast cancer follow-up in primary and secondary care - a systematic review.初级和二级保健中早期乳腺癌随访的选择 - 系统评价。
BMC Cancer. 2012 Jun 13;12:238. doi: 10.1186/1471-2407-12-238.
7
Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer.高风险早期乳腺癌序贯密集型表阿霉素和紫杉醇后卡培他滨联合或不联合长春瑞滨的 I/II 期临床试验的最终结果。
BMC Cancer. 2010 Aug 16;10:430. doi: 10.1186/1471-2407-10-430.
8
Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer.乳腺癌根治术后护士电话随访患者满意度
BMC Cancer. 2010 Apr 30;10:174. doi: 10.1186/1471-2407-10-174.
9
Breast Cancer OncoGuia.乳腺癌诊疗指南
Clin Transl Oncol. 2010 Feb;12(2):113-38. doi: 10.1007/s12094-010-0477-9.
10
Letrozole: a review of its use in the treatment of postmenopausal women with hormone-responsive early breast cancer.来曲唑：用于治疗激素反应性早期乳腺癌绝经后妇女的综述。
Drugs. 2009 Aug 20;69(12):1681-705. doi: 10.2165/10482340-000000000-00000.